$12.32
0.37%
Downside
Day's Volatility :3.04%
Upside
2.69%
38.72%
Downside
52 Weeks Volatility :42.98%
Upside
6.95%
Period | Trubridge Inc | Index (Russel 2000) |
---|---|---|
3 Months | 28.87% | 0.0% |
6 Months | 52.66% | 0.0% |
1 Year | 60.63% | 0.0% |
3 Years | 60.63% | -22.3% |
Market Capitalization | 188.0M |
Book Value | $12.13 |
Earnings Per Share (EPS) | -3.61 |
PEG Ratio | 0.88 |
Wall Street Target Price | 12.2 |
Profit Margin | -15.93% |
Operating Margin TTM | -3.56% |
Return On Assets TTM | -1.26% |
Return On Equity TTM | -26.04% |
Revenue TTM | 336.6M |
Revenue Per Share TTM | 23.64 |
Quarterly Revenue Growth YOY | 0.1% |
Gross Profit TTM | 154.4M |
EBITDA | 7.8M |
Diluted Eps TTM | -3.61 |
Quarterly Earnings Growth YOY | -0.62 |
EPS Estimate Current Year | 0.81 |
EPS Estimate Next Year | 1.05 |
EPS Estimate Current Quarter | 0.17 |
EPS Estimate Next Quarter | 0.34 |
What analysts predicted
Downside of 0.97%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 280.4M | ↑ 1.26% |
Net Income | 17.6M | ↓ 201.24% |
Net Profit Margin | 6.29% | ↑ 12.58% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 274.6M | ↓ 2.06% |
Net Income | 19.7M | ↑ 11.75% |
Net Profit Margin | 7.17% | ↑ 0.88% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 264.5M | ↓ 3.69% |
Net Income | 14.2M | ↓ 27.7% |
Net Profit Margin | 5.39% | ↓ 1.78% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 280.6M | ↑ 6.1% |
Net Income | 18.4M | ↑ 29.37% |
Net Profit Margin | 6.57% | ↑ 1.18% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 326.6M | ↑ 16.4% |
Net Income | 15.9M | ↓ 13.91% |
Net Profit Margin | 4.86% | ↓ 1.71% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 339.4M | ↑ 3.91% |
Net Income | -45.8M | ↓ 388.58% |
Net Profit Margin | -13.49% | ↓ 18.35% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 86.2M | ↑ 75.54% |
Net Income | 3.1M | ↑ 25.01% |
Net Profit Margin | 3.58% | ↓ 1.44% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 84.6M | ↓ 1.87% |
Net Income | -2.8M | ↓ 191.99% |
Net Profit Margin | -3.35% | ↓ 6.93% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 82.7M | ↓ 2.26% |
Net Income | -3.6M | ↑ 25.56% |
Net Profit Margin | -4.31% | ↓ 0.96% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 85.9M | ↑ 3.82% |
Net Income | -42.5M | ↑ 1092.42% |
Net Profit Margin | -49.46% | ↓ 45.15% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 83.2M | ↓ 3.05% |
Net Income | -2.4M | ↓ 94.24% |
Net Profit Margin | -2.94% | ↑ 46.52% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 84.7M | ↑ 1.78% |
Net Income | -4.8M | ↑ 97.43% |
Net Profit Margin | -5.7% | ↓ 2.76% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 327.7M | ↑ 2.99% |
Total Liabilities | 168.0M | ↓ 7.78% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 356.0M | ↑ 8.63% |
Total Liabilities | 171.7M | ↑ 2.21% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 326.3M | ↓ 8.36% |
Total Liabilities | 126.3M | ↓ 26.45% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 383.4M | ↑ 17.49% |
Total Liabilities | 160.8M | ↑ 27.33% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 431.0M | ↑ 12.42% |
Total Liabilities | 199.3M | ↑ 23.93% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 434.4M | ↑ 0.8% |
Total Liabilities | 247.8M | ↑ 24.37% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 436.8M | ↓ 3.1% |
Total Liabilities | 203.3M | ↓ 7.22% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 434.8M | ↓ 0.48% |
Total Liabilities | 204.2M | ↑ 0.46% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 429.5M | ↓ 1.2% |
Total Liabilities | 201.5M | ↓ 1.31% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 434.4M | ↑ 1.14% |
Total Liabilities | 247.8M | ↑ 22.95% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 416.4M | ↓ 4.14% |
Total Liabilities | 231.7M | ↓ 6.48% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 412.3M | ↓ 0.99% |
Total Liabilities | 231.2M | ↓ 0.24% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 23.9M | ↑ 1.21% |
Investing Cash Flow | -978.0K | ↑ 34.71% |
Financing Cash Flow | -17.7M | ↓ 27.94% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 43.6M | ↑ 82.21% |
Investing Cash Flow | -12.5M | ↑ 1177.4% |
Financing Cash Flow | -29.5M | ↑ 66.21% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 49.1M | ↑ 12.71% |
Investing Cash Flow | -6.7M | ↓ 46.66% |
Financing Cash Flow | -37.2M | ↑ 26.05% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 47.7M | ↓ 2.84% |
Investing Cash Flow | -69.9M | ↑ 949.2% |
Financing Cash Flow | 20.9M | ↓ 156.33% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 32.4M | ↓ 32.19% |
Investing Cash Flow | -62.7M | ↓ 10.28% |
Financing Cash Flow | 25.9M | ↑ 23.6% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 9.5M | ↑ 337.75% |
Investing Cash Flow | -6.2M | ↑ 45.09% |
Financing Cash Flow | -3.4M | ↓ 48.04% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 717.0K | ↓ 92.43% |
Investing Cash Flow | -6.0M | ↓ 4.53% |
Financing Cash Flow | 5.7M | ↓ 269.07% |
Sell
Neutral
Buy
Trubridge Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Trubridge Inc | 25.33% | 52.66% | 60.63% | 60.63% | 60.63% |
![]() Solventum Corp | 18.43% | -4.2% | -4.2% | -4.2% | -4.2% |
![]() Doximity, Inc. | 42.51% | 26.66% | 54.18% | -63.01% | -31.43% |
![]() Veeva Systems Inc. | 18.46% | -6.2% | -2.75% | -30.3% | 49.39% |
![]() Ge Healthcare Technologies Inc. | 7.25% | -8.17% | 29.12% | 40.67% | 40.67% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Trubridge Inc | NA | NA | 0.88 | 0.81 | -0.26 | -0.01 | NA | 12.13 |
![]() Solventum Corp | NA | NA | NA | 6.26 | 0.17 | 0.08 | NA | NA |
![]() Doximity, Inc. | 45.43 | 45.43 | 2.42 | 0.9 | 0.17 | 0.11 | NA | 4.92 |
![]() Veeva Systems Inc. | 57.42 | 57.42 | 1.39 | 4.76 | 0.13 | 0.06 | NA | 32.04 |
![]() Ge Healthcare Technologies Inc. | 25.23 | 25.23 | 2.26 | 4.24 | 0.21 | 0.06 | 0.0 | 17.08 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Trubridge Inc | Buy | $188.0M | 60.63% | NA | -15.93% |
![]() Solventum Corp | Hold | $10.8B | -4.2% | NA | 15.73% |
![]() Doximity, Inc. | Hold | $6.7B | -31.43% | 45.43 | 32.53% |
![]() Veeva Systems Inc. | Buy | $35.0B | 49.39% | 57.42 | 23.91% |
![]() Ge Healthcare Technologies Inc. | Buy | $39.9B | 40.67% | 25.23 | 8.1% |
Insights on Trubridge Inc
Revenue is up for the last 2 quarters, 83.24M → 84.73M (in $), with an average increase of 1.8% per quarter
Netprofit is down for the last 2 quarters, -2.44M → -4.83M (in $), with an average decrease of 97.4% per quarter
Vanguard Group Inc
Hotchkis & Wiley Capital Management LLC
Ameriprise Financial Inc
Acadian Asset Management LLC
Federated Hermes Inc
Martin & Co Inc
cpsi is the leading provider of ehr systems to rural, community, and critical access hospitals. the cpsi ehr system provides complete integration of patient data across the healthcare delivery system resulting in improved care delivery and better patient outcomes.
Organization | Trubridge Inc |
Employees | 3219 |
CEO | Mr. Christopher L. Fowler |
Industry | Finance |
A Spac I Acquisition Corp
$12.32
-2.14%
Keyarch Acquisition Corp
$12.32
-2.14%
Connexa Sports Technologies Inc
$12.32
-2.14%
Us Value Etf
$12.32
-2.14%
First Wave Biopharma Inc
$12.32
-2.14%
Global X Msci Next Emerging
$12.32
-2.14%
Fat Projects Acquisition Corp
$12.32
-2.14%
Capital Link Global Fintech
$12.32
-2.14%
Applied Uv Inc
$12.32
-2.14%